Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines

Schizophrenia and Cancer: In 2010 Do We Understand the Connection?

(2017) Chris J Bushe et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment

(2015) Eddy Pasquier et al.   Oncotarget

Adrenergic modulation of immune cells: an update

(2011) Franca Marino et al.   AMINO ACIDS

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study

(2011) Sunil M. Shah et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth

(2011) M. Moreno-Smith et al.   CLINICAL CANCER RESEARCH

Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.

(2011) Steven W. Cole et al.   CLINICAL CANCER RESEARCH

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

(2011) Amal Melhem-Bertrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Do Stress Responses Promote Leukemia Progression? An Animal Study Suggesting a Role for Epinephrine and Prostaglandin-E2 through Reduced NK Activity

(2011) Shelly Inbar et al.   PLoS One

Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells

(2011) D. Chakroborty et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling

(2011) Jillian G. Baker et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action

(2011) C.J. Daly et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients

(2010) Susan K. Lutgendorf et al.   BRAIN BEHAVIOR AND IMMUNITY

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Minireview: New Roles for Peripheral Dopamine on Metabolic Control and Tumor Growth: Let’s Seek the Balance

(2010) Blanca Rubí et al.   ENDOCRINOLOGY

Impact of stress on cancer metastasis

(2010) Myrthala Moreno-Smith et al.   Future Oncology

Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism

(2010) Soon Young Park et al.   INTERNATIONAL JOURNAL OF CANCER

Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis

(2010) Mian M. K. Shahzad et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sympathetic Neurotransmitters and Tumor Angiogenesis—Link between Stress and Cancer Progression

(2010) Jason Tilan et al.   Journal of Oncology

The immunoregulatory role of dopamine: An update

(2009) Chandrani Sarkar et al.   BRAIN BEHAVIOR AND IMMUNITY

Catecholamines Regulate Tumor Angiogenesis

(2009) D. Chakroborty et al.   CANCER RESEARCH

Dopamine released by dendritic cells polarizes Th2 differentiation

(2009) K. Nakano et al.   INTERNATIONAL IMMUNOLOGY

Adrenergic Modulation of Dendritic Cell Cancer Vaccine in a Mouse Model

(2009) Francesca Botta et al.   JOURNAL OF IMMUNOTHERAPY

Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis

(2008) Kazuhisa Nakano et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression

(2008) Eric V. Yang et al.   BRAIN BEHAVIOR AND IMMUNITY

Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network

(2008) Doug Redelman et al.   CELLULAR IMMUNOLOGY

Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma

(2008) S. K. Lutgendorf et al.   CLINICAL CANCER RESEARCH

Dopamine Increases the Efficacy of Anticancer Drugs in Breast and Colon Cancer Preclinical Models

(2008) C. Sarkar et al.   CLINICAL CANCER RESEARCH

Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter

(2008) Masanori Asada et al.   INTERNATIONAL JOURNAL OF CANCER

Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization

(2008) Debanjan Chakroborty et al.   JOURNAL OF CLINICAL INVESTIGATION

Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen

(2008) Fiorenzo Mignini et al.   JOURNAL OF NEUROIMMUNOLOGY

Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays

(2008) Galina P. Kirillova et al.   JOURNAL OF NEUROSCIENCE METHODS

Network pharmacology: the next paradigm in drug discovery

(2008) Andrew L Hopkins   Nature Chemical Biology

Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: Evidence and aspirations

(2007) Nicholas M. Barnes et al.   SEMINARS IN CANCER BIOLOGY